Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines about artificial intelligence. Everyone's talking about AI right now. But see, I've been talking about it for years.

I call it my AI Retirement Playbook. I recommend you check it out now.

Robert Hagemann Biography and Net Worth

Director of Zimmer Biomet

Senior Vice President and Chief Financial Officer of Quest Diagnostics Incorporated until his retirement in July 2013. Mr. Hagemann joined Corning Life Sciences, Inc., a subsidiary of Quest Diagnostics’ former parent company, Corning Incorporated, in 1992, and held roles of increasing responsibility before being appointed Chief Financial Officer of Quest Diagnostics in 1998. Prior to joining Corning, Mr. Hagemann held senior financial positions at Prime Hospitality, Inc. and Crompton & Knowles, Inc. He was also previously employed by Arthur Young & Co., a predecessor company to Ernst & Young. Mr. Hagemann holds a B.S. in accounting from Rider University and an MBA from Seton Hall University.

What is Robert Hagemann's net worth?: The estimated net worth of Robert Hagemann is at least $428,480.00 as of August 28th, 2023. Mr. Hagemann owns 4,000 shares of Zimmer Biomet stock worth more than $428,480 as of December 21st. This net worth evaluation does not reflect any other investments that Mr. Hagemann may own. Learn More about Robert Hagemann's net worth.
How do I contact Robert Hagemann?: The corporate mailing address for Mr. Hagemann and other Zimmer Biomet executives is 345 EAST MAIN STREET, WARSAW IN, 46580. Zimmer Biomet can also be reached via phone at (574) 267-6131 and via email at [email protected]. Learn More on Robert Hagemann's contact information.
Has Robert Hagemann been buying or selling shares of Zimmer Biomet?: Robert Hagemann has not been actively trading shares of Zimmer Biomet over the course of the past ninety days. Most recently, on Monday, August 28th, Robert Hagemann bought 2,000 shares of Zimmer Biomet stock. The stock was acquired at an average cost of $116.48 per share, with a total value of $232,960.00. Following the completion of the transaction, the director now directly owns 4,000 shares of the company's stock, valued at $465,920. Learn More on Robert Hagemann's trading history.
Who are Zimmer Biomet's active insiders?: Zimmer Biomet's insider roster includes Betsy Bernard (Director), Wilfred can Zuilen (Insider), Robert Hagemann (Director), Bryan Hanson (CEO), Arthur Higgins (Director), Sreelakshmi Kolli (Director), Michael Michelson (Director), Chad Phipps (VP), and Sang Yi (Insider). Learn More on Zimmer Biomet's active insiders.
Are insiders buying or selling shares of Zimmer Biomet?: During the last year, insiders at the medical equipment provider sold shares 1 times. They sold a total of 26,156 shares worth more than $3,364,184.72. The most recent insider tranaction occured on February, 22nd when VP Chad F Phipps sold 26,156 shares worth more than $3,364,184.72. Insiders at Zimmer Biomet own 1.0% of the company. Learn More about insider trades at Zimmer Biomet.
Information on this page was last updated on 2/22/2024.

Robert Hagemann Insider Trading History at Zimmer Biomet

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/28/2023	Buy	2,000	$116.48	$232,960.00	4,000

Robert Hagemann Buying and Selling Activity at Zimmer Biomet

Zimmer Biomet Company Overview

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Today's Range

Now: $107.12

$105.34

$107.78

50 Day Range

MA: $108.09

$102.35

$113.02

2 Week Range

Now: $107.12

$101.47

$133.90

Volume

3,969,105 shs

Average Volume

1,504,955 shs

Market Capitalization

$21.32 billion

P/E Ratio

20.37

Dividend Yield

0.89%

Beta

1.02

From Behind the Markets | Ad

My research indicates there is only one investment that can meet AI's unprecedented demand for energy.

Click to get the name and ticker symbol